Profitability Ratios
| Ratio |
Value |
| GP Margin |
61.2% |
| EBIT Margin |
34.5% |
| EBITDA Margin |
38.0% |
| Operating Margin |
33.5% |
| Pretax Margin |
34.0% |
| Cont. Ops Margin |
26.9% |
| Net Margin |
26.9% |
| Bottom Line Margin |
26.9% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
3.10 |
| Quick Ratio |
2.42 |
| Solvency Ratio |
0.723 |
| Cash Ratio |
1.05 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
2.00 |
| Forward PEG |
2.00 |
| Price/Book |
4.28 |
| Price/Sales |
4.99 |
| Price/FCF |
17.10 |
| Price/Op Cash Flow |
15.62 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0921 |
| Debt/Equity |
0.1254 |
| Debt/Capital |
0.1114 |
| Long-Term Debt/Capital |
0.0572 |
| Financial Leverage |
1.36 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
2.09 |
| Operating Cash Flow Ratio |
1.294 |
| Operating Cash Flow/Sales |
31.9% |
| Free Cash Flow/Operating Cash Flow |
91.3% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
6.06 |
| Interest Coverage |
65.1986 |
| Short-Term Operating Cash Flow Coverage |
6.95 |
| Operating Cash Flow Coverage |
2.19 |
| Capital Expenditure Coverage |
11.55 |
| Dividend + Capital Expenditure Coverage |
3.57 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
22.9543% |
| Dividend Yield |
1.2399% |
| Dividend Yield % |
1.2399% |
| Dividend Per Share |
2.4164 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
39.07 |
| EPS |
10.527 |
| Debt/Share |
5.9082 |
| Cash/Share |
10.15 |
| Book Value/Share |
45.51 |
| Tangible BV/Share |
22.27 |
| Equity/Share |
45.51 |
| Operating Cash Flow/Share |
12.479 |
| Capital Expenditure/Share |
1.080 |
| FCF/Share |
11.399 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.794 |
| Earnings Before Tax/EBIT |
1.014 |
| Price/Fair Value |
4.28 |
| Debt/Market Cap |
0.0234 |
| Effective Tax Rate |
20.6% |
| Enterprise Value Multiple |
12.84 |
RMD - ResMed Inc.